Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / JNJ - J&J says Carvykti beat standard drugs in late-stage blood cancer trial

JNJ - J&J says Carvykti beat standard drugs in late-stage blood cancer trial

July, 02 2024 08:23 AM Johnson & Johnson

2024-07-02 08:23:40 ET

More on Johnson & Johnson

Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
Johnson & Johnson: Market Will Regret The Overreaction
Johnson & Johnson (JNJ) Bernstein's 40th Annual Strategic Decisions Conference - (Transcript)
J&J talc claimants lose bid to block company's bankruptcy bid
J&J reports positive phase 3 data for nipocalimab for neuromuscular disease

For further details see:

J&J says Carvykti beat standard drugs in late-stage blood cancer trial

Stock Information

Company Name:	Johnson & Johnson
Stock Symbol:	JNJ
Market:	NYSE
Website:	jnj.com

JNJ JNJ Quote JNJ Short JNJ News JNJ Articles JNJ Message Board

Get JNJ Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.